NEW CLASSES OF NEUROLOGICAL AND ANTIDEPRESSANTS, IN SOLID ORAL FORM, ORIENTED TO BOTH CONTRA (Q2035394): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
||
| Property / financed by | |||
| Property / financed by: Directorate-General for Regional and Urban Policy / rank | |||
Revision as of 08:42, 2 November 2020
Project Q2035394 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | NEW CLASSES OF NEUROLOGICAL AND ANTIDEPRESSANTS, IN SOLID ORAL FORM, ORIENTED TO BOTH CONTRA |
Project Q2035394 in Italy |
Statements
1,489,557.14 Euro
0 references
2,979,114.26 Euro
0 references
50.0 percent
0 references
12 December 2016
0 references
6 July 2019
0 references
UNIVERSITA' DEGLI STUDI DI ROMA LA SAPIENZA
0 references
ITC FARMA
0 references
41°40'3.11"N, 12°30'17.24"E
0 references
L'IDEA PROGETTUALE CONSISTE NELLO SVILUPPO DI UN'AREA R&D E DI NUOVO IMPIANTO DI GRANULAZIONE INDUSTRIALE. LO SCOPO ? QUELLO DI RILANCIARE LA COMPETITIVIT? DELLA ITC FARMA SUL MERCATO DEI FARMACI GENERICI SEGUENDO DUE PERCORSI PARALLELI E SINERGICI, E (Italian)
0 references
The design idea is the development of an area R & d and new industrial granulation plant. THE PURPOSE? HOW TO BOOST COMPETITIVENESS? ITC FARMA ON THE GENERIC DRUG MARKET FOLLOWING TWO PARALLEL AND SYNERGISTIC PATHWAYS; (English)
0 references
Identifiers
F27H18000050007
0 references